Lysiane Richert

4.2k total citations
129 papers, 3.1k citations indexed

About

Lysiane Richert is a scholar working on Pharmacology, Oncology and Hepatology. According to data from OpenAlex, Lysiane Richert has authored 129 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pharmacology, 37 papers in Oncology and 36 papers in Hepatology. Recurrent topics in Lysiane Richert's work include Pharmacogenetics and Drug Metabolism (42 papers), Drug Transport and Resistance Mechanisms (34 papers) and Drug-Induced Hepatotoxicity and Protection (34 papers). Lysiane Richert is often cited by papers focused on Pharmacogenetics and Drug Metabolism (42 papers), Drug Transport and Resistance Mechanisms (34 papers) and Drug-Induced Hepatotoxicity and Protection (34 papers). Lysiane Richert collaborates with scholars based in France, Switzerland and Belgium. Lysiane Richert's co-authors include Bruno Heyd, Catherine Viollon‐Abadie, Eliane Alexandre, Alain Berthelot, Philippe Coassolo, Georges Mantion, Dumrongsak Pekthong, Hélène Martin, C. Parmentier and Philippe Bachellier and has published in prestigious journals such as PLoS ONE, Cancer and Biochemical and Biophysical Research Communications.

In The Last Decade

Lysiane Richert

127 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lysiane Richert France 33 1.1k 810 765 668 524 129 3.1k
M.J. Gómez-Lechón Spain 33 1.2k 1.2× 873 1.1× 773 1.0× 666 1.0× 484 0.9× 77 3.1k
M. José Gómez‐Lechón Spain 38 1.8k 1.7× 1.2k 1.5× 874 1.1× 991 1.5× 671 1.3× 82 4.4k
Fabrice Morel France 32 1.2k 1.1× 1.7k 2.0× 614 0.8× 683 1.0× 322 0.6× 51 3.6k
Martine Daujat‐Chavanieu France 30 1.4k 1.3× 865 1.1× 365 0.5× 825 1.2× 331 0.6× 62 3.0k
Sophie Langouët France 32 690 0.7× 1.8k 2.2× 390 0.5× 450 0.7× 284 0.5× 74 3.5k
Caroline Aninat France 19 620 0.6× 855 1.1× 435 0.6× 329 0.5× 208 0.4× 34 2.2k
Ramiro Jover Spain 43 1.8k 1.7× 1.9k 2.4× 796 1.0× 1.2k 1.8× 679 1.3× 116 5.4k
Sabine Gerbal‐Chaloin France 33 1.7k 1.6× 1.2k 1.5× 295 0.4× 1.1k 1.6× 304 0.6× 63 3.6k
Huichang Bi China 37 1.3k 1.3× 1.9k 2.3× 343 0.4× 842 1.3× 241 0.5× 178 4.2k
Shinsaku Naito Japan 27 966 0.9× 966 1.2× 177 0.2× 1.0k 1.6× 247 0.5× 82 3.1k

Countries citing papers authored by Lysiane Richert

Since Specialization
Citations

This map shows the geographic impact of Lysiane Richert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lysiane Richert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lysiane Richert more than expected).

Fields of papers citing papers by Lysiane Richert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lysiane Richert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lysiane Richert. The network helps show where Lysiane Richert may publish in the future.

Co-authorship network of co-authors of Lysiane Richert

This figure shows the co-authorship network connecting the top 25 collaborators of Lysiane Richert. A scholar is included among the top collaborators of Lysiane Richert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lysiane Richert. Lysiane Richert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Kent, Lindsey, Kingshuk Roy Choudhury, Stephanie Melching‐Kollmuss, et al.. (2024). P02-30 Generation and evaluation of a historical control database for the creation of assay acceptance criteria for a comparative in vitro hepatic enzyme assay. Toxicology Letters. 399. S116–S116. 1 indexed citations
4.
Strupp, Christian, Marco Corvaro, Samuel M. Cohen, et al.. (2023). Increased Cell Proliferation as a Key Event in Chemical Carcinogenesis: Application in an Integrated Approach for the Testing and Assessment of Non-Genotoxic Carcinogenesis. International Journal of Molecular Sciences. 24(17). 13246–13246. 19 indexed citations
5.
Baze, Audrey, et al.. (2023). Comparison of in vitro thyroxine (T4) metabolism between Wistar rat and human hepatocyte cultures. Toxicology in Vitro. 96. 105763–105763. 5 indexed citations
6.
Richert, Lysiane, et al.. (2018). Epistructured catechins, EGCG and EC facilitate apoptosis induction through targeting de novo lipogenesis pathway in HepG2 cells. Cancer Cell International. 18(1). 46–46. 48 indexed citations
7.
Baze, Audrey, C. Parmentier, Delilah Hendriks, et al.. (2018). Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and Coculture with Nonparenchymal Cells. Tissue Engineering Part C Methods. 24(9). 534–545. 70 indexed citations
8.
Keemink, Janneke, et al.. (2017). Extra collagen overlay prolongs the differentiated phenotype in sandwich-cultured rat hepatocytes. Journal of Pharmacological and Toxicological Methods. 90. 31–38. 8 indexed citations
9.
Richert, Lysiane, et al.. (2015). Drug-induced cholestasis detection in cryopreserved rat hepatocytes in sandwich culture. Journal of Pharmacological and Toxicological Methods. 73. 63–71. 23 indexed citations
11.
Heyd, Bruno, et al.. (2012). Isolation of Viable Human Hepatic Progenitors from Adult Livers Is Possible Even After 48 Hours of Cold Ischemia. Tissue Engineering Part C Methods. 19(7). 497–506. 5 indexed citations
12.
Alexandre, Eliane, Audrey Baze, C. Parmentier, et al.. (2012). Plateable cryopreserved human hepatocytes for the assessment of cytochrome P450 inducibility: experimental condition-related variables affecting their response to inducers. Xenobiotica. 42(10). 968–979. 29 indexed citations
14.
Richert, Lysiane, et al.. (2006). REMOVED: Glutathione prevents cytochrome P450 3A induction by dexamethasone in primary cultures of rat hepatocytes. Toxicology in Vitro. 1 indexed citations
15.
Richert, Lysiane, Eliane Alexandre, Tom Lloyd, et al.. (2004). Tissue collection, transport and isolation procedures required to optimize human hepatocyte isolation from waste liver surgical resections. A multilaboratory study. Liver International. 24(4). 371–378. 51 indexed citations
16.
Blanchard, Nadège, et al.. (2004). Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes. European Journal of Pharmaceutical Sciences. 23(2). 189–199. 47 indexed citations
17.
LeCluyse, Edward L., Eliane Alexandre, Geraldine A. Hamilton, et al.. (2004). Isolation and Culture of Primary Human Hepatocytes. Humana Press eBooks. 290. 207–230. 122 indexed citations
18.
Nicod, Laurent, et al.. (2003). Antioxidant status in the liver of hypertensive and metallothionein-deficient mice. Canadian Journal of Physiology and Pharmacology. 81(10). 929–936. 1 indexed citations
19.
Viollon‐Abadie, Catherine, et al.. (2000). Effects of model inducers on thyroxine UDP-glucuronosyl-transferase activity in vitro in rat and mouse hepatocyte cultures. Toxicology in Vitro. 14(6). 505–512. 19 indexed citations
20.
Hietter, Hélène, et al.. (1984). Antagonistic action of cholesterol towards the toxicity of hydroxysterols on cultured hepatoma cells. Biochemical and Biophysical Research Communications. 120(2). 657–664. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026